MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: General Electric Company
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE Healthcare and Nyansa Form Strategic Alliance to Bring Network Performance Analytics Solutions to Health Care - GE Healthcare will distribute the Nyansa Voyance platform in health care facilities, as the sole distributor - Nyansa.com / GEhealthcare.com
GE Healthcare and Nyansa Form Strategic Alliance to Bring Network Performance Analytics Solutions to Health Care

 

NewswireToday - /newswire/ - Chicago, IL, United States, 2019/06/10 - GE Healthcare will distribute the Nyansa Voyance platform in health care facilities, as the sole distributor - Nyansa.com / GEhealthcare.com. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GE Healthcare will distribute the Nyansa Voyance platform in health care facilities, as the sole distributor, to give health care biomed and IT organizations heightened visibility and control over increasingly complex mobile access infrastructure that is now essential to a world-class patient experience

and Palo Alto, CA June 10, 2019 GE Healthcare and Nyansa today announced a strategic alliance under which GE Healthcare will distribute and support the Nyansa Voyance AIOps platform for health care customers. The arrangement, for the first time, provides an advanced analytics solution for biomed and IT professionals to address the increasingly complex mission-critical networks and network-connected patient care devices.

Under the agreement, the companies are integrating the GE CARESCAPE™ Network, the trusted near-real-time patient monitoring network, with Voyance AIOps, the leading AI-based platform for network and device performance management. The arrangement establishes GE Healthcare as the sole distributor of the Nyansa AIOps platform in health care facilities primarily dedicated to patient care, providing customers integrated sales and support of the complete CARESCAPE-Voyance solution. Additionally, GE Healthcare and Nyansa will collaborate on product and technology roadmap to bring to market new network-optimization services during the course of the multi-year agreement.

“The role of the health care CIO and BioMed is rapidly changing, requiring a new approach to integrating the latest device technology with IT infrastructure,” said Gerois Di Marco, General Manager with Clinical Care Solutions at GE Healthcare. “What the industry has lacked is visibility across biomed and IT disciplines to effectively manage performance and utilization of critical care assets at the scale required across wireless and wired networks.”

DIGITAL TRANSFORMATION DRIVING PROFOUND CHANGES IN HEALTH CARE MARKET
As digital transformation within health care takes hold, the widespread adoption of new medical devices, monitoring equipment, and patient record systems requires a new approach that ensures the highest possible levels of device performance and operational assurance using advanced big data network analytics and machine learning technologies that help speed patient care and enhance operation of critical network-connected systems.

As a market-leading provider of health care technology solutions, GE Healthcare is intimately familiar with the evolution of IT infrastructure in the industry. Modern medical devices and clinical communication devices are increasingly deployed on wireless networks as mobility is essential for effective patient care and clinician productivity. The Voyance AIOps platform provides detailed analytics at the device level and across the network from access to application. This provides biomed and IT teams the necessary visibility and a single source of truth to effectively manage device connectivity, performance, and utilization.

“Our collaboration with GE Healthcare will remove roadblocks for CIOs and make them more responsive as they navigate the unique challenges of the health care digital transformation,” said Abe Ankumah, Co-Founder and CEO of Nyansa. “Our expertise in device and network performance, and AI-based analytics, is an ideal complement to the mission critical CARESCAPE platform, and further validates the value of our AIOps solution. Together we deliver a win for clinicians and patients as well as the business.”

“There is untapped potential in optimizing health care networks for all hospital needs, tying together clinicians, biomed devices, and the network infrastructure to deliver a better patient experience,” said Di Marco. “Clinicians get reliable real-time data access from anywhere, organizations can maximize the utilization of expensive critical assets, and incident response or troubleshooting is greatly simplified.”

The Voyance AIOps platform is recognized as the industry’s first and only AI-based operational assurance system that constantly analyzes every client network transaction, correlating this data across every layer of the network to ensure the best possible user and device performance in real-time and historically.

End-to-end analytics, powered by Artificial Intelligence and Machine Learning (AI/ML), provide unmatched visibility and actionable network-optimization recommendations for every device and client connected to healthcare networks the backbone for real-time patient monitoring.

Voyance is currently in use by a number of healthcare customers such as Mission Healthcare and Northeast Georgia Health System companies at the forefront of the health care digital transformation.

About GE Healthcare

GE Healthcare (gehealthcare.com) is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

About Nyansa

Based in Palo Alto, CA, Nyansa (nyansa.com) is a fast-growing innovator of advanced AIOps solutions for the enterprise edge. Founded in September 2013, Nyansa is a privately held company backed by premiere venture investors including Intel Capital and Formation |8.

The company is credited with developing the first full-stack, vendor-agnostic device performance analytics cloud platform called Voyance. With Voyance, organizations are able to automate the performance analysis and security of critical infrastructure device, services and applications to improve user productivity and device performance, security and compliance across wired/wireless access networks. Customers include Tesla, Uber, Stanford, Northeast Georgia Health System, Lululemon, Home Depot and others.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare and Nyansa Form Strategic Alliance to Bring Network Performance Analytics Solutions to Health Care

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Press Office - GEhealthcare.com 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From General Electric Company / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs
The Global Postpartum Hemorrhage Treatment Device Market is Estimated to Grow At 5.10% CAGR by 2027 Finds Inkwood Research
Digital Health to Empower Women and Aging Population with mHealth, Telemedicine, Femtech and AI Finds Frost & Sullivan
Technological Advancements Propels the Global Healthcare Analytics Market At 27.13% CAGR by 2027 Reports Inkwood Research
SC Life Sciences Conference to Feature J&J Innovation Leader Michal Preminger, 40 National Speakers
American Well® Applauded by Frost & Sullivan for Driving Telehealth’s Next Growth Wave with its Pioneering Strategy
Liquid Biopsy Applications Drives the Global DNA Sequencing Market At a CAGR of 17.46% by 2027 Finds Inkwood Research
The Growing Geriatric Population Propels the Global Diabetes Drugs Market At A CAGR of 6.50%, 2027 Finds Inkwood Research
Technological Development are Driving the Global Dental Imaging Market at a CAGR of 8.38% by 2027 Finds Inkwood Research
Clinical Decision Support Systems Revolutionize the EMR to Become the Leader for Patient Empowerment Finds Frost & Sullivan
The Global Cosmetic Surgery and Procedure Market is Growing At 5.76% CAGR through 2027 Reports Inkwood Research
LiveWell Project Funded to Engage People Living with Dementia as Research Partners
Gain Cutting-Edge Insights into Growth Opportunities, Trends and Technologies Shaping the European Healthcare Industry in 2020
Enterprise Content Management Market Doubles in Size with Healthcare Digitization Says Frost & Sullivan
Deciphex Applauded by Frost & Sullivan for its Machine Learning-powered Patholytix Preclinical Digital Pathology Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2019 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)